Research progress on molecular biomarkers of acute myeloid leukemia
Acute myeloid leukemia (AML) is the most common type of adult acute leukemia. The pathophysiology of the disease has been studied intensively at the cellular and molecular levels. At present, cytogenetic markers are an important basis for the early diagnosis, prognostic stratification and treatment...
Main Authors: | Pei-Yuan Yin, Rui-Wen Wang, Rui Jing, Xing Li, Jing-Hua Ma, Kai-Min Li, Hua Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1078556/full |
Similar Items
-
Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
by: Habsah Aziz, et al.
Published: (2017-12-01) -
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
by: Carolina Alarcón-Payer, et al.
Published: (2022-09-01) -
CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA
by: Gh. Toogeh, et al.
Published: (2003-08-01) -
CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA
by: Gh. Toogeh, et al.
Published: (2003-12-01) -
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
by: Xianwen Yang, et al.
Published: (2019-09-01)